Orthogonal Thinker is a biotech holding and operating company that acquires and accelerates companies.
Orthogonal Thinker is a biotech holding company, acquiring and accelerating companies engaged in DEA registered psilocybin, psychoactive compounds, clean label foods, and plant sciences. Empowering health, mental wellness and emotional intelligence through food, technology, and psychoactive compounds.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 29, 2020 | Seed | $6M | 1 | Republic capital | — | Detail |
Oct 1, 2019 | Convertable Note | — | 1 | Republic capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Republic capital | Yes | Seed |